Resources from the same session
Presentation of clinical cases of advanced NSCLC patients treated with immunotherapy and subsequent diagnosis of EGFR E20I mutations: Considerations of efficacy and safety
Presenter: S. M. Lim, KR
Session: Session 5 – Optimising use of EGFR E20I mutations
Resources:
Slides
Webcast